Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success
Abstract Substance P, previously dismissed as a therapeutic target for migraine due to the failure of neurokinin-1 receptor antagonists, warrants renewed attention. Building on the success of therapies targeting the calcitonin gene-related peptide (CGRP) system and pituitary adenylate cyclase-activa...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-01-01
|
| Col·lecció: | The Journal of Headache and Pain |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s10194-025-01959-8 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|